Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Pharmacy regulator supports joint approach to culture of openness

The General Pharmaceutical Council (GPhC) is one of eight healthcare professional regulators that has published a joint statement supporting the view that healthcare professionals have a duty to be honest and open with patients when things go wrong.

The statement, which reinforces a duty of candour on pharmacists and pharmacy technicians, is the latest response by the GPhC and other regulators to the findings of the 2013 Francis report into the failings of the Mid Staffordshire NHS Foundation Trust. 

“This duty for pharmacy professionals to be candid with patients and others is already reflected in our regulatory framework; both in our standards and in our guidance,” says GPhC chief executive Duncan Rudkin. “However, this joint statement is a very helpful step forward in promoting a wider culture in healthcare where openness and transparency is the norm.”

Rudkin says the statement, published on 13 October 2014, supports the GPhC’s work around openness and transparency, including its review of the standards for conduct, ethics and performance which is looking at how the organisation can be “more explicit about the need to be candid”. Other work focusing on the duty of candour includes the new standards around initial education and training and its new guidance on sanctions, he says.

The other regulators that have endorsed the joint statement are the General Chiropractic Council, the General Dental Council, the General Medical Council, the General Optical Council, the General Osteopathic Council, the Nursing and Midwifery Council and the Pharmaceutical Society of Northern Ireland.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066793

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.